{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:04:36Z","timestamp":1792065876396,"version":"4.4.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.autrev.2025.103765","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:09:04Z","timestamp":1739318944000},"page":"103765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?"],"prefix":"10.1016","volume":"24","author":[{"given":"Franz F.","family":"Konen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Wurster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schwenkenbecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gerritzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina C.","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Eichhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Harrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Isenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Lewczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lewerenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Leypoldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Regeniter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Roskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Ruprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Spreer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwig","family":"Strik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Uhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Wildemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Hannich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"S\u00fc\u00dfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skripuletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103765_bb0005","series-title":"ECTRIMS: 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis","first-page":"18","article-title":"Revisions of the McDonald criteria","author":"Montalban","year":"2024"},{"issue":"2","key":"10.1016\/j.autrev.2025.103765_bb0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2025.103765_bb0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fneur.2019.00188","article-title":"Impact of the McDonald criteria 2017 on early diagnosis of relapsing-remitting multiple sclerosis","volume":"10","author":"Schwenkenbecher","year":"2019","journal-title":"Front Neurol"},{"issue":"17","key":"10.1016\/j.autrev.2025.103765_bb0020","doi-asserted-by":"crossref","first-page":"e1641","DOI":"10.1212\/WNL.0000000000012726","article-title":"Effect of changes in MS diagnostic criteria over 25 years on time to treatment and prognosis in patients with clinically isolated syndrome","volume":"97","author":"Tintore","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.autrev.2025.103765_bb0025","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1212\/WNL.0000000000013016","article-title":"MAGNIMS study group. Performance of the 2017 and 2010 revised McDonald criteria in predicting MS diagnosis after a clinically isolated syndrome: a MAGNIMS study","volume":"98","author":"Filippi","year":"2022","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.autrev.2025.103765_bb0030","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"Andersson","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.autrev.2025.103765_bb0035","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3390\/cells10113056","article-title":"The increasing role of Kappa free light chains in the diagnosis of multiple sclerosis","volume":"10","author":"Konen","year":"2016","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.autrev.2025.103765_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM197601082940206","article-title":"Bence-Jones proteins and light chains of immunoglobulins (second of two parts)","volume":"294","author":"Solomon","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103765_bb0045","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1100\/tsw.2011.65","article-title":"Immunoglobulin free light chain dimers in human diseases","volume":"11","author":"Kaplan","year":"2011","journal-title":"Sci World J"},{"key":"10.1016\/j.autrev.2025.103765_bb0050","series-title":"Klinische Liquordiagnostik","first-page":"208","article-title":"Elektrophoreseverfahren\u2014Nachweis und Bedeutung von oligoklonalen Banden","author":"Wurster","year":"2009"},{"issue":"6","key":"10.1016\/j.autrev.2025.103765_bb0055","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103765_bb0060","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2006.01493.x","article-title":"EFNS Task Force. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force","volume":"13","author":"Deisenhammer","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2025.103765_bb0065","series-title":"Electrophoresis 082","first-page":"250","article-title":"Demonstration of Oligoclonal IgG in the unconcentrated CSF by silver stain","author":"Wurster","year":"1983"},{"issue":"12","key":"10.1016\/j.autrev.2025.103765_bb0070","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1001\/archneur.58.12.2044","article-title":"Oligoclonal band number as a marker for prognosis in multiple sclerosis","volume":"58","author":"Avasarala","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2025.103765_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2015.10.009","article-title":"Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes","volume":"289","author":"Dalla Costa","year":"2015","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103765_bb0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/clinchem\/41.2.256","article-title":"External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF\/serum quotients","volume":"41","author":"Reiber","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2025.103765_bb0085","series-title":"Praktische Liquordiagnostik","first-page":"132","article-title":"Nachweis oligoklonaler Banden: Grundlage der Liquoranalytik","author":"Wurster","year":"2021"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2025.103765_bb0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10072-017-3034-2","article-title":"Cerebrospinal fluid analysis and the determination of oligoclonal bands","volume":"38","author":"Gastaldi","year":"2017","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.autrev.2025.103765_bb0095","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00415-017-8480-5","article-title":"RIREMS group (rising Italian researchers in multiple sclerosis). A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band","volume":"264","author":"Ferraro","year":"2017","journal-title":"J Neurol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103765_bb0100","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3390\/biomedicines10092202","article-title":"Evidence for an intrathecal immunoglobulin synthesis by kappa free light chains in neurological patients with an isolated band in isoelectric focusing","volume":"10","author":"Weiss","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.autrev.2025.103765_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cca.2020.04.029","article-title":"Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusing","volume":"507","author":"S\u00fc\u00dfe","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.autrev.2025.103765_bb0110","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1212\/01.wnl.0000198253.35119.83","article-title":"Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS","volume":"66","author":"Masjuan","year":"2006","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.autrev.2025.103765_bb0115","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/ijms18102061","article-title":"Clinically isolated syndrome according to McDonald 2010: intrathecal IgG synthesis still predictive for conversion to multiple sclerosis","volume":"18","author":"Schwenkenbecher","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2025.103765_bb0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.autrev.2025.103765_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.0000000000006583","article-title":"Misdiagnosis of multiple sclerosis: impact of the 2017 McDonald criteria on clinical practice","volume":"92","author":"Solomon","year":"2019","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.autrev.2025.103765_bb0130","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/brain\/awab147","article-title":"Classification of neurological diseases using multi-dimensional CSF analysis","volume":"144","author":"Gross","year":"2021","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.autrev.2025.103765_bb0135","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/01.wnl.0000237343.93389.35","article-title":"Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct","volume":"67","author":"Imrell","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103765_bb0140","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fneur.2019.00584","article-title":"The influence of blood contamination on cerebrospinal fluid diagnostics","volume":"10","author":"Schwenkenbecher","year":"2019","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103765_bb0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1212\/WNL.36.2.238","article-title":"High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations","volume":"36","author":"Durelli","year":"1986","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.autrev.2025.103765_bb0150","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/diagnostics12030720","article-title":"Decreased intrathecal concentrations of free light chains kappa in multiple sclerosis patients taking very high effective disease-modifying treatment","volume":"12","author":"S\u00fc\u00dfe","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"10.1016\/j.autrev.2025.103765_bb0155","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/jnnp.49.11.1308","article-title":"Oligoclonal \u201cfingerprint\u201d of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon","volume":"49","author":"Confavreux","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2025.103765_bb0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2013.09.003","article-title":"The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis","volume":"264","author":"Axelsson","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2025.103765_bb0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.06.029","article-title":"Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients","volume":"180","author":"Cross","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2025.103765_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.msard.2018.10.006","article-title":"Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study","volume":"27","author":"Rejdak","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.autrev.2025.103765_bb0175","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001030","article-title":"Effects of Natalizumab therapy on intrathecal immunoglobulin G production indicate targeting of Plasmablasts","volume":"8","author":"Schl\u00fcter","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"10.1016\/j.autrev.2025.103765_bb0180","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1177\/1352458512463483","article-title":"Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy","volume":"19","author":"Harrer","year":"2013","journal-title":"Mult Scler"},{"issue":"11","key":"10.1016\/j.autrev.2025.103765_bb0185","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1177\/1352458519863983","article-title":"Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis","volume":"26","author":"Larsson","year":"2020","journal-title":"Mult Scler"},{"issue":"10","key":"10.1016\/j.autrev.2025.103765_bb0190","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/diagnostics10100856","article-title":"Kappa index versus CSF Oligoclonal bands in predicting multiple sclerosis and infectious\/inflammatory CNS disorders","volume":"10","author":"Ferraro","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.autrev.2025.103765_bb0195","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.clineuro.2018.09.031","article-title":"Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset","volume":"174","author":"Vasilj","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.autrev.2025.103765_bb0200","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1515\/cclm-2020-1037","article-title":"Inter-center agreement in the interpretation of oligoclonal bands","volume":"59","author":"Mariotto","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"10.1016\/j.autrev.2025.103765_bb0205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/elps.201400339","article-title":"Capillary isoelectric focusing immunoassay as a new nanoscale approach for the detection of oligoclonal bands","volume":"36","author":"Halbgebauer","year":"2015","journal-title":"Electrophoresis"},{"issue":"5","key":"10.1016\/j.autrev.2025.103765_bb0210","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00415-016-8094-3","article-title":"Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis","volume":"263","author":"Halbgebauer","year":"2016","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103765_bb0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00868439","article-title":"Detection of oligoclonal IgA in cerebrospinal fluid samples by an isoelectric focusing procedure","volume":"241","author":"Withold","year":"1994","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103765_bb0220","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1212\/WNL.59.4.555","article-title":"Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS","volume":"59","author":"Villar","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.autrev.2025.103765_bb0225","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.10441","article-title":"Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis","volume":"53","author":"Villar","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2025.103765_bb0230","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3389\/fimmu.2019.01110","article-title":"Investigation of Oligoclonal IgG bands in tear fluid of multiple sclerosis patients","volume":"10","author":"H\u00fcmmert","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103765_bb0235","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1038\/s41598-021-89514-8","article-title":"Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing","volume":"11","author":"Bachhuber","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.autrev.2025.103765_bb0240","first-page":"551","article-title":"Combined use of kappa free light chain index and Isoelectrofocusing of Cerebro-spinal fluid in diagnosing multiple sclerosis: performances and costs","volume":"63","author":"Crespi","year":"2017","journal-title":"Clin Lab"},{"issue":"4","key":"10.1016\/j.autrev.2025.103765_bb0245","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1515\/cclm-2017-0285","article-title":"Application of \u03ba free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm","volume":"56","author":"Valencia-Vera","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"10.1016\/j.autrev.2025.103765_bb0250","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1515\/cclm-2022-0602","article-title":"Validation of ELISA assays for the calculation of FLC indices for the diagnosis of intrathecal immunoglobulin synthesis","volume":"61","author":"Heim","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2025.103765_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105125","article-title":"A comparison of measles-rubella-zoster reaction, oligoclonal IgG bands, oligoclonal kappa free light chains and kappa index in multiple sclerosis","volume":"81","author":"Zondra Revendova","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10.1016\/j.autrev.2025.103765_bb0260","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/labmed\/lmz073","article-title":"Clinical use of \u03ba free light chains index as a screening test for multiple sclerosis","volume":"51","author":"Agnello","year":"2020","journal-title":"Lab Med"},{"issue":"4","key":"10.1016\/j.autrev.2025.103765_bb0265","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000775","article-title":"Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS","volume":"7","author":"Duell","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.autrev.2025.103765_bb0270","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/brainsci10060324","article-title":"Kappa free light chains and IgG combined in a novel algorithm for the detection of multiple sclerosis","volume":"10","author":"Gudowska-Sawczuk","year":"2020","journal-title":"Brain Sci"},{"issue":"1","key":"10.1016\/j.autrev.2025.103765_bb0275","doi-asserted-by":"crossref","first-page":"20329","DOI":"10.1038\/s41598-020-77029-7","article-title":"Intrathecal kappa free light chains as markers for multiple sclerosis","volume":"10","author":"Vecchio","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2025.103765_bb0280","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2019.06.016","article-title":"Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands","volume":"496","author":"Altinier","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2025.103765_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577287","article-title":"Free light chain kappa and the polyspecific immune response in MS and CIS - application of the hyperbolic reference range for most reliable data interpretation","volume":"346","author":"S\u00fc\u00dfe","year":"2020","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103765_bb0290","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10875-005-5371-9","article-title":"Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry","volume":"25","author":"Desplat-J\u00e9go","year":"2005","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103765_bb0295","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3390\/cells9040842","article-title":"The impact of immunomodulatory treatment on kappa free light chains as biomarker in Neuroinflammation","volume":"9","author":"Konen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2025.103765_bb0300","doi-asserted-by":"crossref","DOI":"10.1177\/11795735211042166","article-title":"The influence of renal function impairment on kappa free light chains in cerebrospinal fluid","volume":"13","author":"Konen","year":"2021","journal-title":"J Cent Nerv Syst Dis"},{"issue":"7","key":"10.1016\/j.autrev.2025.103765_bb0305","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/biomedicines10071629","article-title":"Diagnostic cerebrospinal fluid biomarker in early and late onset multiple sclerosis","volume":"10","author":"Konen","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.autrev.2025.103765_bb0310","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.msard.2016.01.001","article-title":"The effects of intrathecal rituximab on biomarkers in multiple sclerosis","volume":"6","author":"Topping","year":"2016","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.autrev.2025.103765_bb0315","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/jnc.15500","article-title":"Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: a real-world investigation","volume":"159","author":"Rosenstein","year":"2021","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.autrev.2025.103765_bb0320","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/cells10030616","article-title":"Kappa free light chains in the context of blood contamination, and other IgA- and IgM-related cerebrospinal fluid disease pattern","volume":"10","author":"Hannich","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.autrev.2025.103765_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166556","article-title":"Assessment of intrathecal free light chain synthesis: comparison of different quantitative methods with the detection of oligoclonal free light chains by isoelectric focusing and affinity-mediated immunoblotting","volume":"11","author":"Zeman","year":"2016","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.autrev.2025.103765_bb0330","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/ene.13667","article-title":"Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands","volume":"25","author":"S\u00fc\u00dfe","year":"2018","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103765_bb0335","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/biom12050677","article-title":"On behalf of Rirems rising researchers in Ms. inter-laboratory concordance of cerebrospinal fluid and serum kappa free light chain measurements","volume":"12","author":"Natali","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.autrev.2025.103765_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1385231","article-title":"Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis","volume":"15","author":"Dekeyser","year":"2024","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103765_bb0345","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/biomedicines10102470","article-title":"Saliva free light chains in patients with neuro-Sj\u00f6gren","volume":"10","author":"Konen","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.autrev.2025.103765_bb0350","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/brainsci12040475","article-title":"Kappa free light chains in cerebrospinal fluid in inflammatory and non-inflammatory neurological diseases","volume":"12","author":"Konen","year":"2022","journal-title":"Brain Sci"},{"issue":"13","key":"10.1016\/j.autrev.2025.103765_bb0355","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.3390\/jcm10132922","article-title":"Free immunoglobulin light chains in patients with tick-borne encephalitis: before and after treatment","volume":"10","author":"Gudowska-Sawczuk","year":"2021","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.autrev.2025.103765_bb0360","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1515\/cclm-2019-0315","article-title":"Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis - a pilot study","volume":"57","author":"Tjernberg","year":"2019","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"10.1016\/j.autrev.2025.103765_bb0365","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1515\/cclm-2018-0028","article-title":"Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis","volume":"56","author":"Hegen","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"10.1016\/j.autrev.2025.103765_bb0370","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000892","article-title":"Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy","volume":"7","author":"S\u00fc\u00dfe","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"10.1016\/j.autrev.2025.103765_bb0375","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/ene.15897","article-title":"Relevance of kappa free light chains index in patients with aquaporin-4 or myelin-oligodendrocyte-glycoprotein antibodies","volume":"30","author":"Deschamps","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2025.103765_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577122","article-title":"Kappa free light chains index in the differential diagnosis of multiple sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders","volume":"339","author":"Cavalla","year":"2020","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103765_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103693","article-title":"MOGAD: a comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally","volume":"24","author":"Trewin","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2025.103765_bb0390","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1212\/WNL.0000000000201662","article-title":"Significance of myelin oligodendrocyte glycoprotein antibodies in CSF: a retrospective multicenter study","volume":"100","author":"Carta","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.autrev.2025.103765_bb0395","doi-asserted-by":"crossref","first-page":"17224","DOI":"10.1038\/s41598-023-44427-6","article-title":"The role of intrathecal free light chains kappa for the detection of autoimmune encephalitis in subacute onset neuropsychiatric syndromes","volume":"13","author":"Bertram","year":"2023","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.autrev.2025.103765_bb0400","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s00415-008-0954-z","article-title":"Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis","volume":"255","author":"Presslauer","year":"2008","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103765_bb0405","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.3390\/ijms19123796","article-title":"The persisting significance of Oligoclonal bands in the dawning era of kappa free light chains for the diagnosis of multiple sclerosis","volume":"19","author":"Schwenkenbecher","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2025.103765_bb0410","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/13524585221134217","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a consensus statement","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult Scler"},{"issue":"12","key":"10.1016\/j.autrev.2025.103765_bb0415","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1007\/s00415-023-11952-3","article-title":"A dynamic interpretation of \u03baFLC index for the diagnosis of multiple sclerosis: a change of perspective","volume":"270","author":"Toscano","year":"2023","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103765_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0044-1779690","article-title":"Concordance rate between oligoclonal bands and the kappa index in patients with suspected multiple sclerosis (MS)","volume":"82","author":"Domingues","year":"2024","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.autrev.2025.103765_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578091","article-title":"Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases","volume":"379","author":"Michetti","year":"2023","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2025.103765_bb0430","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cca.2019.07.027","article-title":"Diagnostic relevance of free light chains in cerebrospinal fluid - the hyperbolic reference range for reliable data interpretation in quotient diagrams","volume":"497","author":"Reiber","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2025.103765_bb0435","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fimmu.2019.00641","article-title":"CSF free light chains as a marker of intrathecal immunoglobulin synthesis in multiple sclerosis: a blood-CSF barrier related evaluation in a large cohort","volume":"10","author":"Senel","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103765_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089945","article-title":"Kappa free light chains: diagnostic and prognostic relevance in MS and CIS","volume":"9","author":"Presslauer","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.autrev.2025.103765_bb0445","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/diagnostics9040194","article-title":"Reiber\u2019s diagram for kappa free light chains: the new standard for assessing intrathecal synthesis?","volume":"9","author":"Schwenkenbecher","year":"2019","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.autrev.2025.103765_bb0450","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1515\/cclm-2023-1468","article-title":"Implications of monoclonal gammopathy and isoelectric focusing pattern 5 on the free light chain kappa diagnostics in cerebrospinal fluid","volume":"63","author":"Hannich","year":"2024","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"10.1016\/j.autrev.2025.103765_bb0455","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1093\/brain\/awac220","article-title":"The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria","volume":"145","author":"Arrambide","year":"2022","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.autrev.2025.103765_bb0460","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1177\/13524585211064121","article-title":"The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter study","volume":"28","author":"Bernardi","year":"2022","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.autrev.2025.103765_bb0465","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/1352458519845844","article-title":"Kappa free light chains is a valid tool in the diagnostics of MS: a large multicenter study","volume":"26","author":"Leurs","year":"2020","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.autrev.2025.103765_bb0470","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1352458515594044","article-title":"Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: a multicenter study","volume":"22","author":"Presslauer","year":"2016","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.autrev.2025.103765_bb0475","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200049","article-title":"Soci\u00e9t\u00e9 francophone de la Scl\u00e9rose En plaques (SFSEP). Kappa free light chain biomarkers are efficient for the diagnosis of multiple sclerosis: a large multicenter cohort study","volume":"10","author":"Levraut","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"15\u201316","key":"10.1016\/j.autrev.2025.103765_bb0480","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10354-022-00912-7","article-title":"Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity","volume":"172","author":"Hegen","year":"2022","journal-title":"Wien Med Wochenschr"},{"issue":"11","key":"10.1016\/j.autrev.2025.103765_bb0485","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/1352458516681503","article-title":"Prognostic value of free light chains lambda and kappa in early multiple sclerosis","volume":"23","author":"Voortman","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2025.103765_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105402","article-title":"Prognostic value of cerebrospinal fluid biomarkers in multiple sclerosis: the key role of kappa free light chains and a multivariate predictor for disease progression","volume":"82","author":"Miklu\u0161ov\u00e1","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2025.103765_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1223514","article-title":"Kappa free light chains index in multiple sclerosis very long-term prognosis","volume":"14","author":"Arroyo-Pereiro","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103765_bb0500","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200156","article-title":"Kappa free light chain index predicts disease course in clinically and radiologically isolated syndromes","volume":"10","author":"Levraut","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"10.1016\/j.autrev.2025.103765_bb0505","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1007\/s00415-023-11817-9","article-title":"Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple sclerosis","volume":"270","author":"Rosenstein","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2025.103765_bb0510","article-title":"Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study","volume":"91","author":"Hegen","year":"2023","journal-title":"E Bio Med"},{"key":"10.1016\/j.autrev.2025.103765_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1106028","article-title":"High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis","volume":"14","author":"Rosenstein","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103765_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105734","article-title":"Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients","volume":"88","author":"Tortosa-Carreres","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2025.103765_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577992","article-title":"K index utility as diagnostic and prognostic biomarker in the assessment of patients with suspected multiple sclerosis","volume":"373","author":"Cutell\u00e8","year":"2022","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2025.103765_bb0530","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.msard.2019.02.001","article-title":"Kappa free light chains could predict early disease course in multiple sclerosis","volume":"30","author":"Vecchio","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.autrev.2025.103765_bb0535","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/ijms26020826","article-title":"Biomarkers of intrathecal synthesis may be associated with cognitive impairment at MS diagnosis","volume":"26","author":"Virgilio","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2025.103765_bb0540","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/13524585221134213","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review and meta-analysis","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2025.103765_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.06.014","article-title":"Intrathecal oligoclonal IgG synthesis in multiple sclerosis","volume":"262","author":"Petzold","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"13","key":"10.1016\/j.autrev.2025.103765_bb0550","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1212\/WNL.0000000000003152","article-title":"The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study","volume":"87","author":"Solomon","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.autrev.2025.103765_bb0555","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/diagnostics11010037","article-title":"Evidence of Oligoclonal bands does not exclude non-inflammatory neurological diseases","volume":"11","author":"Pannewitz-Makaj","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.autrev.2025.103765_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109066","article-title":"Kappa-index: real-life evaluation of a new tool for multiple sclerosis diagnosis","volume":"241","author":"Marlas","year":"2022","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103765_bb0565","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3390\/biom12111690","article-title":"A new laboratory workflow integrating the free light chains kappa quotient into routine CSF analysis","volume":"12","author":"Hannich","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.autrev.2025.103765_bb0570","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00415-024-12826-y","article-title":"Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis","volume":"272","author":"Vecchio","year":"2024","journal-title":"J Neurol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:04:04Z","timestamp":1741665844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":114,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1568997225000254"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103765","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103765"}}